A new study discovered it Diabetes medication And weight loss could significantly reduce the death rate among Americans.
Researchers at Swiss RE, a reinsurance company in Zurich, Switzerland, estimated that GLP-1 drugs could reduce all-cause mortality rates in the US by 2045 by 6.4%.
The UK was projected to have a 5% or more reduction in mortality over the same 20 years.
Can GLP-1 weight loss drugs like Ozempic be “all medicines”?
The US and the UK share high obesity rates and “strong uptake” of GLP-1 drugs, the researchers said in a press release.
America has the highest obesity rate in the world. The adult population is obese. Approximately 30% of UK adults are obese.
Researchers say obesity is one of the factors that “stopped progress in life expectancy.” These causes include heart disease, stroke, and Alzheimer’s disease. Many cancers.
“By improving baseline risk factors, GLP-1 drugs can contribute to improved mortality over time, saving millions of people from untimely death,” the researchers commented.
Why Microdosing Ozempics are as common as taking multivitamins
To maximize the benefits of GLP-1 drugs, individuals need to implement lifestyle changes that support the long term Health improvement“The experts advised.
No sustainable changes like Diet and exercisestudies have shown that the effects of weight recovery and rebound are common.
Paul Murray, CEO of Life & Health Reinsurance at Swiss Re, commented on these findings in a press release, saying that GLP-1 drugs hold “an important promise that will help defeat the obesity epidemic.”
“Our research highlights that the full benefit comes from the fact that it comes from beyond the drug,” he writes. “As an insurance company, we are in a position to build partnerships, support policies and encourage people to create meaningful things. Changes in lifestyle It focuses on prevention. ”
Murray added: “If this is right, we can strengthen our insurance safety net and contribute to those living longer and healthier lives.”
Click here to sign up for our health newsletter
Recent research has revealed this GLP-1 drug It can improve a variety of conditions beyond weight loss and diabetes.
These include heart, kidneys, liver, skin conditions, and arthritis. Cognitive declineaddiction, and even certain cancers.
Dr. Sue Dekotis, a New York-based Triple Board Certified Weight Loss Physician, saw in an interview with Fox News Digital how patients experienced improvement. Various conditions With these medicines.
Experts say that fat cells burned by increased insulin from GLP-1 drugs produce cytokines that cause inflammation in the body, leading to autoimmune diseases, cancer and other problems.
For health articles, please visit www.foxnews.com/health
“By reducing the amount of fat cells in the body, we reduce all these inflammatory cytokines,” she said. “That’s why we see so many of the effects we see.”
“It’s important to do that in the right way, treat these drugs with real respect, treat your body with respect and understand that this is a great tool when used in the right way.”
